NCT03702660View on ClinicalTrials.gov

Effect of GIP After a Meal in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

January 23, 2018

Study Completion Date

January 23, 2018

Conditions
Type2 Diabetes
Interventions
OTHER

GIP(3-30)NH2

Peptide derived from the naturally occuring gut hormone GIP

OTHER

Peripheral venous cannulation

Intravenous access for infusions

OTHER

GLP-1

Peptide infusion

Trial Locations (1)

2900

Center for Diabetes Research, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03702660 - Effect of GIP After a Meal in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter